2020-2025 Global Radiopharmaceuticals in Nuclear Medicine Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)

Nuclear medicine : Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. A Radiopharmaceutical is a drug that can be used either for diagnostic or therapeutic purposes.
This report elaborates the market size, market characteristics, and market growth of the Radiopharmaceuticals in Nuclear Medicine industry, and breaks down according to the type, application, and consumption area of Radiopharmaceuticals in Nuclear Medicine. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Radiopharmaceuticals in Nuclear Medicine in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Radiopharmaceuticals in Nuclear Medicine market covered in Chapter 13:
POLATOM
Institute of Isotopes Co., Ltd.
Siemens Healthcare (Subsidiary Of Siemens AG)
Institute Of Radioelement (IRE)
Bracco Imaging S.P.A.
IBA Group
Curium Pharma
Covidien, Plc

In Chapter 6, on the basis of types, the Radiopharmaceuticals in Nuclear Medicine market from 2015 to 2025 is primarily split into:
Diagnostic Radiopharmaceuticals
Therapy Radiopharmaceuticals
Enriched Stable Isotopes

In Chapter 7, on the basis of applications, the Radiopharmaceuticals in Nuclear Medicine market from 2015 to 2025 covers:
Diagnostic Application
Therapeutic Application
Research
Pharmaceutical
Other

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others

Years considered for this report:

Historical Years:

2015-2019

Base Year:

2019

Estimated Year:

2020

Forecast Period:

2020-2025